• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    Ketogenic diets and Alzheimer’s disease

    2017-04-04 15:52:25KlusLngeKthrinLngeEwelinMkulskGertrudYukikoNkmurAndresReissmnnShigehikoKnyJohimHuser

    Klus W.Lnge,Kthrin M.Lnge,Ewelin Mkulsk-Gertrud,Yukiko Nkmur,Andres Reissmnn,Shigehiko Kny,Johim Huser

    a Department of Experimental Psychology,University of Regensburg,93040 Regensburg,Germany

    b Department of Psychology,University of Winchester,UK

    c Graduate School of Information Science,Nara Institute of Science and Technology,Japan

    Abstract Alzheimer’s disease(AD)is a progressive neurodegenerative disorder characterized by decline in cognitive functions and associated with the neuropathological hallmarks of amyloid β-peptide plaques and neurofibrillar tangles.Cerebral glucose uptake and metabolism deteriorate in AD and this hypometabolism precedes the onset of clinical signs in AD.The early decline in brain glucose metabolism in AD has become a potential target for therapeutic intervention.This has led to investigations assessing the supplementation of the normal glucose supply with ketone bodies which are produced by the body during glucose deprivation and can be metabolized by the brain when glucose utilization is impaired.The present review provides a synopsis of preclinical studies and clinical trials assessing the effica y of ketogenic diets in the treatment of AD.Both the direct administration of ketone bodies and the use of high-fat,low-carbohydrate ketogenic diets have been shown to be efficaciou in animal models of AD and clinical trials with AD patients.The mechanism underlying the effica y of ketogenic diets remains unclear,but some evidence points to the normalization of aberrant energy metabolism.At present there is only limited evidence of the usefulness of ketogenic diets in AD.However,this dietary approach seems to be promising and deserves further clinical investigations.

    Keywords:Alzheimer’s disease;Ketone bodies;Ketogenic diet;Therapy

    1.Introduction

    Alzheimer’s disease (AD) is a chronic neurodegenerative disease and the most common cause of dementia,accounting for over 50% ofindividuals affected [1].This disease is characterized by progressive memory impairment and cognitive decline interfering with daily life activities.The most common early symptom of AD is difficult remembering recent events.The symptoms of patients with advancing disease can include executive dysfunction,disorientation,problems with language,mood swings,behavioral changes and impaired self-care [2].Age-standardized prevalence for individuals aged over 60 years varied between 5%and 7%in most world regions[3].An estimated 35.6 million people lived with dementia worldwide in 2010,with numbers expected to almost double every 20 years[3].

    AD has a long preclinical phase of several decades and the most important risk factor for AD is increasing age.Impaired vascular health has been shown to be another major risk factor for cognitive decline and interventions for cardiovascular risk may therefore improve cognitive health at the population level[4,5].Other lifestyle-related factors,such as obesity,diabetes,smoking,diet,physical and mental inactivity,have been suggested to play a role in dementia,and potential preventive measures related to these risk factors should be investigated[6].

    AD is neuropathologically define by neuronal loss and the accumulation of extracellular amyloid β-peptide (Aβ)-containing plaques and intracellular hyperphosphorylated tau protein-containing neurofibrillar tangles in the brain [7].The accumulation of abnormally folded Aβ and tau proteins in amyloid plaques and neuronal tangles,respectively,appear to be causally associated with the neurodegeneration in AD[8].However,a linear causality between amyloid and tau and AD seems to be too simplistic an assumption made by the original amyloid hypothesis[9].The cognitive decline in AD is associated with progressive synaptic dysfunction and neuronal atrophy,mainly in the neocortex,limbic system and subcortical brain areas[7].

    The etiology of AD is unknown,but both genetic and environmental risk factors have been suggested to be involved.Genome-wide association studies have shown more than 20 genetic loci to be associated with the risk of AD[10].The identifie AD risk genes are related to lipid and cholesterol processing,inflammator responses and the immune system.The majority of these genes affect Aβ production and clearance,emphasizing the special role of this pathway in the pathogenesis of AD.Carriers of the presenilin 1 mutation have the highest risk of AD [10].Another major susceptibility gene is the apolipoprotein E(ApoE)gene which is related to sporadic late-onset AD,the epsilon 4 (E4) variant of ApoE was found to increase the risk for AD[10].

    Curative therapies for AD are not available and supportive care plays an important role in the treatment of patients with AD.Symptomatic treatments providing temporary alleviation of the symptoms of AD without modifying the disease progression include drugs such as acetylcholinesterase inhibitors and the glutamate antagonist memantine [1].Most of these drugs offer at best a moderate symptomatic effect.Other therapeutic strategies focus on anti-amyloid approaches,including active and passive immunization,γ-secretase and β-secretase inhibitors,and antiaggregation drugs[1].A further understanding of the etiopathogenesis of AD is needed in order to develop disease-modifying therapies which can prevent,delay or treat the symptoms of AD.Type 2 diabetes and insulin resistance are the main lifestyle-related risk factors for AD.Lifestylemodifying approaches including diet and physical exercise may show beneficia effects in the prevention and early treatment of AD.

    The accumulation of Aβ and the development of AD have been proposed to be related to dietary factors.For example,the finding of a Dutch study suggested that diets rich in saturated fat and cholesterol increase the risk of several types of dementia[11].However,a subsequent 6-year follow-up of the same study population found no correlation between fat consumption and dementia[12].Another large study of elderly participants found only weak trends between cognitive decline and the intake of saturated fat and cholesterol as assessed using a food questionnaire[13].

    The finding of recent investigations have suggested that caloric restriction prevents age-related neuronal damage and may be useful in the prevention and treatment of AD [14].Hypotheses linking caloric restriction to cognitive capability include anti-inflammator mechanisms,reduction of neural oxidative stress,promotion of synaptic plasticity as well as induction of various stress and neurotrophic/neuroprotective factors [14].Caloric restriction may also prevent Aβ neuropathology in AD transgenic animal models [14].A relative recent dietary approach to the treatment of AD is the administration of ketogenic diets.

    2.Development of ketogenic diets

    During infancy and early childhood,ketone bodies play an important role beside glucose as oxidizable substrates and energy source for the brain[15]since their blood plasma concentrations are high and an abundance of monocarboxylic acid transporters render the blood–brain barrier greatly permeable to ketone bodies[16].In adult humans,high ketone body concentrations are found during fasting and on a high-fat diet.In addition,the permeability of the blood–brain barrier increases with fasting[16].Ketone bodies when present at sufficien concentrations to saturate metabolism can support most,if not all,basal(non-signaling)neuronal energy needs and up to approximately half of the activity-dependent oxidative needs of neurons[17].

    When food was scarce,ketosis may have been a survival mechanismduringhumanevolution[18].Foodscontaininglarge amounts of carbohydrates have relatively recently become a part of the human diet and may be more evolutionarily discordant than high fat diets[19].High carbohydrate diets stimulate insulin signaling and lead to a suppression oflipid metabolism and ketogenesis [20].The evolutionary switch to diets high in carbohydrates(ketodeficien diet)has been hypothesized to play a role in the development of AD[21].

    It has long been known that fasting has anticonvulsant properties.The ketogenic diet was developed in the 1920s to mimic the physiological alterations observed in prolonged fasting[22]when energy is mainly derived from the utilization of body fat or dietary fat.This diet was successfully used as a therapeutic approach for seizures[23].Due to the availability of antiepileptic drugs the ketogenic diet was not in use for decades,but was in favor again in the 1990s,particularly in the therapy of pharmacoresistant epilepsy.The ketogenic diet is very high in fat and low in carbohydrates and is believed to simulate the effects of starvation by primarily metabolizing fat as energy supply[24].While fasting the organism metabolizes stored body fat via lipolysis and the ensuing β-oxidation of fatty acids leads to the production of acetoacetate,β-hydroxybutyrate and acetone which can easily cross the blood–brain barrier.These ketone bodies can be used as precursors for the generation of adenosine triphosphate(ATP).

    The ketogenic diet has now become an established and effective nonpharmacological treatment for epilepsy [25–27].A number of patients with intractable epilepsy have been shown to become seizure-free or to have a significan reduction in seizure frequency during the administration of a ketogenic diet and even following the discontinuation of the diet,suggesting disease-modifying effects in some patients with epilepsy [27].Several mechanisms underlying the anticonvulsive effects of ketone bodies have been proposed [27],including changes in ATP production,altered brain pH affecting neuronal excitability,direct inhibitory effects of ketone bodies or fatty acids on ion channels,and shifts in amino acid metabolism [28–30].Since at least some glucose is required for the synthesis of glutamate and the maintenance of homeostasis during glutamatergic activity[31],a ketogenic diet very low in carbohydrates may prevent seizures by compromising the formation of the excitatory neurotransmitter glutamate(for further details see Ref.[32]).This hypothesis is supported by the fact that the replacement of glucose by β-hydroxybutyrate in the medium decreases glutamate availability in cultured neurons[33].

    Beside its effica y in the treatment of refractory epilepsy,the ketogenic diet has been suggested to be useful in the therapy of neurodegenerative and neuromuscular diseases including AD,Parkinson’sdisease,amyotrophiclateralsclerosisandmitochondrial disorders[34].The ketogenic diet is likely to have different mechanisms in different diseases[29].

    3.Rationale for the use of ketogenic diets in AD

    Energy deprivation is harmful to neurons and may contribute to the pathophysiology of AD since brain glucose uptake and metabolism have been shown to be impaired in AD.A decline in cerebral blood flw and mean cerebral oxygen utilization was found to be correlated with increasing severity of dementia[35].Compared to elderly controls,individuals with senile dementia showed a decrease in regional glucose use in the posterior cingulate,temporal,parietal and prefrontal cortex[36]and this hypometabolism correlated significantl with measures of cognitive functioning[37].The defici in brain glucose metabolism is an early feature of AD and could be the consequence of a reduced need for glucose due to synaptic loss and neuronal cell death.However,brain glucose hypometabolism has also been observed in preclinical stages of AD long before the occurrence of cognitive deficits Clinical studies have reported a decline in cerebral glucose utilization prior to the onset of clinically measurable cognitive decline and the diagnosis of AD[38,39].Brain hypometabolism preceding the onset of clinical signs of AD may presymptomatically contribute to the risk of AD[40].Early degeneration of the locus coeruleus,the noradrenergic brain stem nucleus,may be a reason for the compromised glucose metabolism in AD since the locus coeruleus stimulates glucose metabolism,at least in astrocytes (for review see Ref.[41]).Glucose metabolism has also been shown to decrease in healthily aging individuals,but the reduction is more pronounced in ApoE4 carriers than in matched non-carriers [42].A low regional cerebral metabolic rate of glucose appears to occur early in the AD process long before the onset of clinical signs of dementia or neuronal loss and plaque deposition in the brain[43].Brain hypometabolism has been suggested to indicate a risk for the future development of dementia [44].A vicious circle may gradually develop in which latent presymptomatic brain hypometabolism leads to chronic brain energy deprivation,deteriorating neuronal function,further decline in demand for glucose and progression of cognitive impairment[40].The reason why reduced brain glucose metabolism develops is unknown,but defective brain glucose transport,disrupted glycolysis,or impaired mitochondrial function may be involved(for a detailed account of the consequences ofimpaired energy metabolism in AD see Ref.[32]).Mitochondrial DNA is maternally inherited in humans,and it is therefore noteworthy that reduced brain glucose metabolism before the onset of cognitive decline is more pronounced in elderly individuals with a maternal family history of AD than in those with paternal or no family history[45].

    The adult human brain represents about 2% of total body weight but requires approximately 20% of the entire body’s supply of energy.It relies almost exclusively on glucose as energy substrate and stores only small amounts of glycogen.Fatty acids cannot cross the blood–brain barrier and are not available as energy source in the brain.Although glucose is the brain’s major fuel,the ketone bodies β-hydroxybutyrate and acetoacetate produced by the liver from fatty acids can be used as replacement for glucose during starvation,fasting or demanding exercise[18,46].Fasting or an intake of very small amounts of carbohydrates induces ketosis due to hepatic β-oxidation oflong-chain fatty acids.In comparison to glucose,ketone bodies produce a larger amount of energy due to changes in mitochondrial ATP production that they induce [47,48].Ketone bodies can bypass the block in glycolysis caused by impaired insulin function [49].While glucose hypometabolism has repeatedly been demonstrated in patients with AD [24],the metabolism of ketone bodies was unchanged,at least in the early disease stages[50].In a state of brain energy crisis,ketone bodies can be used as an auxiliary and alternative fuel for brain metabolism[16].Since fuel hypometabolism in the AD brain appears to be specifito glucose,the administration of ketone bodies may overcome the reduction in glucose uptake and metabolism and improve the energy defici in the brain.Both calorie restriction and consumption of a ketogenic diet reduce carbohydrate intake and lead to a compensatory rise in ketone bodies.This has been shown to improve mitochondrial function,reduce the expression of apoptotic and inflammator mediators and increase the activity of neurotrophic factors[51].Dietary carbohydrate reduction appears to have neuroprotective effects [52]and ketone bodies have been demonstrated to protect neurons against multiple types of neuronal injury and to have mitochondrial effects similar to those following calorie restriction or ketogenic diet[51].In summary,an increase in ketone body supply,provided by a ketogenic diet or by the administration of ketone esters,would be expected to alleviate the impaired brain glucose metabolism preceding the onset of AD.

    4.Ketone bodies in a cell culture model of AD

    Neuroprotective properties of ketone bodies have been investigated in cell cultures.A proteolytic fragment of the β chain of amyloid precursor protein,Aβ1–42,is toxic to hippocampal cells.The exposure of 6-day cultured hippocampal neurons from 18-day-old embryos to 5 μM Aβ1–42 reduced cell number as well as neurite number and length compared to control[53].When the cells were simultaneously exposed to 4 mM Dβ-hydroxybutyrate,the surviving cell number doubled and both cell size and neurite outgrowth increased in comparison with cells exposed to Aβ1–42 alone [53].These finding show that β-hydroxybutyrate may provide neuroprotection from Aβ1–42 toxicity.In addition,exposure of cells to ketone bodies for 14 h increased both surviving cell number and neurite number compared to control cells,suggesting that ketone bodies can act as growth factors to neurons in culture[53].The ability of ketone bodies to protect neurons in culture suggests that defects in mitochondrial energy generation contribute to the pathophysiology of AD and that ketone bodies may have therapeutic potential.This needs to be investigated using in vivo studies.

    5.Ketogenic diets in animal models of AD

    Animal models have provided insight into the underlying mechanisms of AD and have been useful in the preclinical evaluation of potential treatments[54].Genetically modifie animals exhibiting critical aspects of AD neuropathology have helped understand the function of genes associated with AD.Several studies have used genetically modifie rodents as AD models in order to assess the therapeutic effica y of ketogenic diet and ketone bodies in regard to pathological changes and behavioral deficits

    In a transgenic mouse model,the effects of a ketogenic diet composed of very high saturated fat and extremely low carbohydrate content were investigated [55].These mice exhibit significan levels of soluble Aβ at three months of age and extensive plaque deposition at age 12–14 months [56].Two groups of female transgenic mice carrying the “London” APP mutation (APP/V717I) were fed ad libitum for 43 days either a standard diet composed of high carbohydrate/low fat chow or a ketogenic diet composed of very low carbohydrate/high saturated fat chow[55].Animals fed the ketogenic diet showed greatly increased serum ketone body concentrations and significantly reduced brain Aβ40 and Aβ42 levels while no changes in cognitive performance were found[55].The findin that Aβ reduction did not improve cognitive performance may be due to the relatively short intervention.Long-term administration of the ketogenic diet may be required in order to produce behavioral effects.

    Another study assessed the effects of a ketogenic diet in two transgenic mouse lines[57].Five-month-old APP/PS1 mice(model of amyloid deposition)and Tg4510 mice(model of tau deposition) were fed either a ketogenic or a control diet for three months.Behavioral testing during the last two weeks of treatment showed that mice fed the ketogenic diet performed significantl better on a rotarod than those in the control group independent of genotype [57].In the open fiel test,both transgenic mouse lines presented increased locomotor activity compared to nontransgenic,age-matched controls,and this effect was not influence by the ketogenic diet[57].The radial arm water maze identifie learning deficit in both transgenic lines without significan differences between the diets.Tissue measures of amyloid,tau,astroglial and microglial markers in transgenic lines showed no differences between mice fed the ketogenic or control diet[57].These finding suggest that ketogenic diets may play a role in enhancing motor performance in the two mouse models while not affecting amyloid or tau deposition.

    An effect on amyloid or tau deposition may not be necessary in order to achieve improvements in cognitive functions following dietary interventions.In the triple-transgenic mouse model ofAD(3xTgADmice),twodifferentenergyrestrictionregimens(40%calorie restriction and intermittent fasting)were tested in regard to their ability to protect against cognitive decline[58].Groups of 3xTgAD mice were maintained on calorie restriction,intermittent fasting or an ad libitum control diet starting at three months of age.Half of the mice in each diet group were tested using the open fiel and the Morris swim task at age 10 months and the other half at 17 months [58].At 10 months 3xTgAD mice on the control diet showed reduced exploratory activity compared to non-transgenic mice and 3xTgAD mice on calorie restriction and intermittent fasting [58].No significan differences were found in performance in the water maze between genotypes or diets in 10-month-old mice[58].In 17-month-old 3xTgAD mice,the calorie restriction and intermittent fasting groups exhibited higher levels of exploratory behavior and better performance in the swim task,compared to 3xTgAD mice on the control diet[58].3xTgAD mice in the calorie restriction group showed lower levels of Aβ1–40,Aβ1–42 and phosphorylated tau in the hippocampus compared to the control diet group,while Aβ and phosphorylated tau levels were not decreased in 3xTgAD mice in the intermittent fasting group[58].These find ings suggest that intermittent fasting,which may increase levels of ketone bodies,can ameliorate age-related cognitive deficit without affecting Aβ or tau levels.

    Medium chain triglycerides are easily converted to ketone bodies.A study assessing the effects of ketosis induced by the administration of medium chain triglycerides was performed in aged dogs,a natural model of amyloidosis [59].The dogs received a 2 g/kg/day dose of medium chain triglycerides for 2 months.Compared to age-matched controls,markedly improved mitochondrial function was observed in aged dogs receiving medium chain triglycerides [59].This effect was most prominent in the parietal lobe.In addition,there was a trend towards a decrease in Aβ levels in the parietal lobe[59].These results suggest that short-term administration of medium chain triglycerides improves energy metabolism in the aged canine brain.

    Mitochondrial bioenergetic deficit have been shown to be closely related to the pathogenesis of AD [60].These deficit activate a cascade of neurotoxic outcomes,including an increase in oxidative stress and the production of Aβ,which impair synaptic functions and lead to neuronal death [61].A decline in mitochondrial bioenergetics has also been demonstrated to precede AD pathology in the female triple-transgenic AD(3xTgAD)mouse model[62].In the brains of these mice,a temporary increase in the expression of ketogenic markers was also found,indicating a compensatory energy production mechanism[62].In order to investigate if this alternative energy supply could be preserved,the effects of 2-deoxy-D-glucose (2-DG)administration on brain AD pathology were assessed [63].2-DG is known to competitively block glucose metabolism and to induce ketogenesis in the liver,i.e.a compensatory production of ketone bodies as alternative energy substrates.

    Six-month-old female 3xTgAD mice were fed either a diet containing 0.04%2-DG or a regular diet(AIN-93G)for seven weeks.The 2-DG diet markedly increased serum ketone body levels and brain expression of enzymes required for ketone body metabolism.Mice fed the 2-DG diet showed a significan reduction of both amyloid precursor protein (APP) and amyloid beta (Aβ) oligomers as well as a significan increase in α-secretase and decrease in γ-secretase expression,indicating that 2-DG induced a shift towards a non-amyloidogenic pathway[63].In comparison to the control diet,the 7-week dietary 2-DG administration significantl induced ketogenesis,sustained mitochondrial bioenergetic function,and reduced Aβ pathology.In summary,these preclinical finding suggest that the dietary 2-DG intervention can delay the progression of bioenergetic deficit and Aβ production in the brain[63].

    The hypothesis that a ketone ester-based diet can ameliorate AD pathogenesis was tested in the 3xTgAD mouse model[64].Beginning at a presymptomatic age,male 3xTgAD mice were fed either a diet containing a physiological enantiomeric precursor of ketone bodies or an isocaloric carbohydrate diet.The mice fed a precursor of ketone bodies showed reduced Aβ and hyperphosphorylated tau deposition in the hippocampus,amygdala and cortex [64].In behavioral tests performed at 4 and 7 months following the initiation of the experimental diet,3xTgAD mice exhibited significan improvements in learning and memory tests as assessed using the Morris water maze [64].These results demonstrate that long-term feeding of ketone esters reduces Aβ accumulation and hyperphosphorylated tau pathology and improves cognitive functions in a mouse model of AD.The preclinical finding suggest that a ketone ester-containing diet can potentially retard the disease process and improve cognitive functions of patients with AD.

    Ketone bodies cannot provide additional citric acid cycle intermediates which limits the anabolic capacity of the cell.The supplementation of ketogenic diet with anaplerotic compounds such as triheptanoin may increase the effects of the diet[65].The hypothesis that supplementation with triheptanoin can increase the beneficia effects of ketogenic diet was tested in a rodent model of familial AD,the APP/PS1 transgenic mouse.Three-month-old APP/PS1 mice were fed a ketogenic diet plus triheptanoin supplementation for three months.This treatment reduced the memory impairment of the mice at the age of 6 months.Aβ production and deposition were not significantl changed by either ketogenic diet alone or the combination diet[65].However,mice fed with triheptanoin-rich ketogenic diet demonstrated a reduction in astroglial response in the vicinity of Aβ plaques and a decrease in the expression of the pro-inflammator cytokine interferon-γ in astrocytes.Ketogenic diets supplemented with anaplerotic compounds may therefore delay cognitive impairment by acting via astrocytes in energy metabolism responses[65].These results suggest the potential therapeutic utility of triheptanoin-rich ketogenic diets at early stages of AD.

    In summary,several reports have indicated neuroprotective properties of ketone bodies in animal models of AD.However,the translational concordance between these preclinical studies and clinical trials in humans needs to be investigated.

    6.Clinical trials of ketogenic diets in AD

    As shown above,several strategies are available in order to induce ketosis,i.e.the administration of (1) high-fat,lowcarbohydrate,low-protein,ketogenic diets,(2) medium chain triglycerides,and(3)ketone bodies.These approacheshavebeen usedinafewclinicaltrialsassessingtheeffica yofketonebodies in patients with AD.

    Oral administration of medium chain triglycerides has been shown to induce ketosis in humans[66].Due to their short fatty acid chain lengths,medium chain trigycerides do not underlie the regulation imposed on long chain fatty acids and they undergo obligatory oxidation.When fatty acids are oxidized at high rates,large amounts of acetyl coenzyme A are generated.Following the intake of a sufficientl large amount of medium chain triglycerides,the excess acetyl coenzyme A produced exceeds the capacity of the citric acid cycle and leads to the synthesis of ketone bodies in liver mitochondria[67].In contrast to the ketogenic diet,medium chain triglycerides are oxidized regardless of the consumption of other nutrients,and a restriction of carbohydrate or protein intake is therefore not necessary.

    The effects of an increase in plasma ketone body levels on cognitive functions were investigated in older adults with memory disorders[66].Elevation of ketone levels was induced using an oral dose of medium chain triglycerides.On separate days,20 subjects with AD or mild cognitive impairment imbibed a drink containing emulsifie medium chain triglycerides or placebo.A significan increase in β-hydroxybutyrate levels was observed 90 min after administration when cognitive testing was performed.The increase in β-hydroxybutyrate was moderated by ApoE genotype[66].In ApoE4-positive participants,β-hydroxybutyrate levels continued to rise between the 90 and 120-min blood sampling in the treatment condition,while levels in ApoE4-negative subjects remained constant[66].The administration of medium chain triglycerides facilitated performance on the AD Assessment Scale-Cognitive Subscale in ApoE4-negative participants,but not in ApoE4-positive participants.Higher ketone values were associated with greater improvement in paragraph recall under medium chain triglyceride treatment relative to placebo across all participants [66].Future studies need to assess the therapeutic benefit of medium chain triglycerides and the mediation by ApoE-4 status in patients with AD.

    An oral ketogenic compound,AC-1202,was administered to individuals with probable AD in order to assess if chronic induction of mild ketosis can improve cognitive performance[68,69].AC-1202 is a form of medium chain triglycerides and elevates serum ketone bodies even in the presence of dietary carbohydrates.Daily administration of AC-1202 over 90 days was evaluated in 152 patients with a diagnosis of mild to moderate AD in a randomized,placebo-controlled,doubleblind,parallel-group study.The participants were on a normal diet and continued taking their usual AD medications.Primary cognitive end points were mean change from baseline in the AD Assessment Scale-Cognitive subscale(ADAS-Cog),and global scores in the AD Cooperative Study — Clinical Global Impression of Change (ADCS-CGIC).AC-1202 was compared to placebo in several population groups,including intention-to-treat (ITT),per protocol,and dosage compliant groups.The results were also stratifie by ApoE4 carriage status.AC-1202 significantl increased serum ketone bodies two hours after administration compared to placebo [68,69].Each population group showed a significan difference between AC-1202 and placebo in mean change from baseline in ADAS-Cog score on days 45 and 90.Effects were most notable in subjects who did not carry the ApoE4 allele,patients with the ApoE4 genotype did not benefit Adverse events were more frequently observed in participants receiving AC-1202 and concernedmainlytransient,mildtomoderategastrointestinaleffects[68,69].Insummary,theoralketogeniccompoundAC-1202was found to have memory-enhancing effects after 45 and 90 days of treatment.This medium-chain triglyceride preparation of fractionated coconut oil(caprylic trigyceride)has been approved for the treatment of AD in the USA[70].

    In another study,ketosis was induced by a diet very low in carbohydrates[71].Twenty-three older adults with mild cognitive impairment were randomly assigned to either a high carbohydrate or very low carbohydrate diet.Following the 6-week intervention period,improved verbal memory performance was observed in participants receiving the low carbohydrate diet[71].Changes in calorie intake,insulin level,and weight were not correlated with memory performance for the entire sample,although a trend toward a moderate relationship between insulin and memory was observed within the low carbohydrate group[71].Ketone levels were positively correlated with memory performance [71].These finding indicate that a very low carbohydrate diet can improve memory function in older adults with increased risk for AD.The mechanism of action underlying this cognitive change remains to be established.

    A new way to produce therapeutic hyperketonemia has recently been described [72].In a 63-year-old patient with younger-onset sporadic AD for 12 years and a pretreatment Mini-Mental State Examination score of 12,a firs trial was conducted of prolonged oral administration of a potent ketogenic agent,(R)-3-hydroxybutyl(R)-3-hydroxybutyrate(ketone monoester) [73].This ketone monoester has been shown to improve cognitive performance and reduce Aβ and tau deposition in cognition-relevant areas in a mouse model of AD[64].The compound was administered as a food supplement without changes in the habitual diet.In the 20-month trial,the ketone ester produced repeated diurnal increases in plasma βhydroxybutyrate levels and improved cognitive performance,mood,affect,behavior and activities of daily living[72].Plasma ketonelevelsandthepatient’sperformanceseemedtoberunning parallel,with interaction and conversation improving noticeably at higher levels and declining as ketone concentrations approached baseline.Anincrease inthepatient’sself-sufficien y and a reduced need for supervision were also noted[72].However,properly designed case–control studies need to confir these observations.

    In summary,a moderate improvement in AD symptoms has been found following dietary supplementation with relatively low concentrations of ketone bodies.In individuals with epilepsy,the highest possible portion of the calorie need may have to be provided in the form of ketone bodies in order to decrease glucose metabolism sufficientl to compromise glutamate production in neurons.By contrast,much lower amounts of ketone bodies can have therapeutic effects in AD probably by different mechanisms.The smaller ketone body doses administered in AD may owe their effect mainly to the support of energy metabolism,but they might also inhibit the release of gliotransmitter glutamate[32].

    7.Possible problems with ketogenic diets in AD

    Physicians are commonly afraid of ketosis because severe hyperketonemia induced by insulin deficien y may be a lifethreatening condition in patients with type 1 diabetes.It is,however,important to distinguish between diabetic ketoacidosis and nutritional ketosis(“physiological ketosis”[74]).Ketoacidosis is a pathological metabolic state characterized by extreme ketosis which cannot be adequately regulated due to a lack ofinsulin.The resulting pH imbalance may be fatal.However,this kind of metabolic derangement is not possible in ketosis induced by dietary changes.

    The evaluation of side effects of ketogenic diets in patients with AD is difficul due to the small number of available clinical trials.Major adverse reactions have not been reported in the literature.Transient,mild to moderate gastrointestinal effects such as diarrhea,dyspepsia,and flatulenc were reported in patients receiving a formulation of medium chain triglycerides[68,69].The administration of a ketogenic diet to 83 obese patients for 24 weeks did not produce any significan adverse effects[75].

    Strict adherence to low carbohydrate consumption is needed in ketogenic diets.This may be difficul for AD patients due to theiralteredfoodpreferencetowardcarbohydrate-richandsweet foods[76,77].The administration of medium chain triglycerides in order to induce ketosis may be favorable in AD since there is no need for dietary change.

    8.Conclusions and future directions

    More than 50%of all dementia cases are caused by AD.There are currently no therapies available to prevent or at least delay the progression of the disease.The early and region-specifidecline in brain glucose metabolism in AD has become a potential target for therapeutic intervention.This has led to investigations assessing the supplementation of the normal glucose supply with ketone bodies which are produced by the body during glucose deprivation and can be metabolized by the brain when glucose utilization is impaired.

    The toxic effects of Aβ1–42 on hippocampal neurons in culture were reversed by D-β-hydroxybutyrate,suggesting that ketone bodies may have neuroprotective effica y [53].Some animal studies have shown that high-fat diets are associated with elevated Aβ loads[78,79]while decreased Aβ levels were observed following the administration of a ketogenic diet high in saturated fat and very low in carbohydrates[55].These seemingly conflictin finding can be explained by the fact that,in the earlier studies,fat was added to the diet without a marked reduction in carbohydrates.Dietary strategies attempting to decrease Aβ levels should therefore consider the interactions of dietary componentsandtheirmetabolicoutcomes,i.e.totalcalories,carbohydrate levels and the production of ketone bodies need to be taken into account.The translational relevance of these finding should be confirme in clinical studies with AD patients.

    Data from clinical trials suggest that medium chain triglycerides improve cognition in patients with mild to moderate AD in ApoE4-negative patients[68,69].In order to establish the role of medium chain triglycerides in the therapy of AD,genetic screening including ApoE4 carriage status would have to be routinely performed in patients.A novel approach to induce therapeutic hyperketonemia is the administration of ketone monoesters[72].A case report using this method presented promising results.However,case–control studies need to confir this observation.

    Best results of dietary ketogenic approaches in AD may be expected by early presymptomatic treatment [80].However,a reliable diagnostic identificatio ofindividuals with minimal neuropathological alterations would be necessary.It is currently unclear whether or not cognitive decline can be delayed if brain hypometabolism is improved preclinically or early in the course of the disease.Future studies need to demonstrate that the neuroprotective properties of ketone bodies can influenc or prevent AD-related impairment of clinically relevant functions such as cognition.In this respect,there is at present only limited evidence of the usefulness of ketogenic diets in AD.However,this novel dietary approach seems to be interesting and deserves further clinical investigations in AD.

    国产av不卡久久| 日本免费a在线| 美女脱内裤让男人舔精品视频| 夜夜爽夜夜爽视频| 天美传媒精品一区二区| 嫩草影院入口| 亚洲欧美中文字幕日韩二区| 好男人在线观看高清免费视频| 色综合站精品国产| 日本av手机在线免费观看| 精品久久久精品久久久| 久久午夜福利片| 一区二区三区四区激情视频| 2018国产大陆天天弄谢| 亚洲综合色惰| 久久久久精品久久久久真实原创| 久久精品人妻少妇| 国产精品99久久久久久久久| 有码 亚洲区| 91午夜精品亚洲一区二区三区| 亚洲最大成人中文| 国产白丝娇喘喷水9色精品| 国产精品麻豆人妻色哟哟久久 | 亚洲成人精品中文字幕电影| 亚洲欧美精品自产自拍| 亚洲精品一二三| 97热精品久久久久久| 午夜福利在线观看吧| 国产高清国产精品国产三级 | 久久精品久久久久久噜噜老黄| 卡戴珊不雅视频在线播放| 日韩av免费高清视频| 日韩av免费高清视频| 全区人妻精品视频| 一级黄片播放器| 久99久视频精品免费| 亚洲伊人久久精品综合| 国产黄色视频一区二区在线观看| 欧美区成人在线视频| 欧美成人a在线观看| 成人毛片60女人毛片免费| 国产大屁股一区二区在线视频| 禁无遮挡网站| 国精品久久久久久国模美| 18禁裸乳无遮挡免费网站照片| 日韩欧美精品v在线| 国产精品国产三级专区第一集| 亚洲熟女精品中文字幕| 色综合亚洲欧美另类图片| 精品午夜福利在线看| 天堂√8在线中文| 日韩成人av中文字幕在线观看| 午夜福利视频精品| 亚洲国产色片| 水蜜桃什么品种好| 日本黄色片子视频| 99热这里只有精品一区| 十八禁国产超污无遮挡网站| 精品久久久久久久人妻蜜臀av| 99re6热这里在线精品视频| 亚洲国产高清在线一区二区三| 国产成人精品久久久久久| 免费看a级黄色片| 3wmmmm亚洲av在线观看| 七月丁香在线播放| 国产精品爽爽va在线观看网站| av卡一久久| 水蜜桃什么品种好| 国产久久久一区二区三区| av在线老鸭窝| 看黄色毛片网站| 日韩欧美精品免费久久| 国产淫片久久久久久久久| 精品一区二区三区视频在线| 婷婷色av中文字幕| 精品亚洲乱码少妇综合久久| 成年女人在线观看亚洲视频 | 秋霞伦理黄片| 国产精品.久久久| 边亲边吃奶的免费视频| 婷婷色麻豆天堂久久| 久久这里只有精品中国| av国产免费在线观看| 国产成年人精品一区二区| 成人特级av手机在线观看| 少妇猛男粗大的猛烈进出视频 | 久久韩国三级中文字幕| 在线观看免费高清a一片| 国产精品久久久久久av不卡| 成人性生交大片免费视频hd| 亚洲美女搞黄在线观看| 精品久久久久久久人妻蜜臀av| 国产黄片美女视频| 男女啪啪激烈高潮av片| 美女大奶头视频| 亚洲精品乱码久久久久久按摩| 欧美日韩在线观看h| 亚洲欧洲国产日韩| 一本—道久久a久久精品蜜桃钙片 精品乱码久久久久久99久播 | 日本黄大片高清| 神马国产精品三级电影在线观看| 日本色播在线视频| 亚洲av福利一区| 久久97久久精品| 亚洲国产精品成人久久小说| 狠狠精品人妻久久久久久综合| 精品国内亚洲2022精品成人| 大香蕉久久网| 国产亚洲5aaaaa淫片| 亚洲18禁久久av| 久久韩国三级中文字幕| 亚洲精品成人av观看孕妇| 欧美高清性xxxxhd video| 久久久精品免费免费高清| 网址你懂的国产日韩在线| 22中文网久久字幕| 亚洲精品成人久久久久久| 男女边吃奶边做爰视频| 日韩av在线大香蕉| 最近的中文字幕免费完整| 丝袜喷水一区| 欧美人与善性xxx| 成人毛片60女人毛片免费| 婷婷六月久久综合丁香| 一级a做视频免费观看| 一个人观看的视频www高清免费观看| 免费在线观看成人毛片| 国产成人精品一,二区| 人妻制服诱惑在线中文字幕| 午夜日本视频在线| 99久久精品热视频| 我要看日韩黄色一级片| 高清欧美精品videossex| 久久久久精品性色| 色播亚洲综合网| 色视频www国产| 久久人人爽人人爽人人片va| 久久精品国产自在天天线| 亚洲美女视频黄频| 色综合站精品国产| 国产片特级美女逼逼视频| 久热久热在线精品观看| 建设人人有责人人尽责人人享有的 | 嫩草影院新地址| 久久精品夜色国产| 亚洲国产精品国产精品| 国产成人一区二区在线| 边亲边吃奶的免费视频| 啦啦啦在线观看免费高清www| 观看美女的网站| 亚洲国产色片| 嫩草影院入口| 99精国产麻豆久久婷婷| 亚洲,欧美,日韩| 日韩av在线免费看完整版不卡| 黑人欧美特级aaaaaa片| 亚洲欧美日韩另类电影网站| 人妻 亚洲 视频| 免费女性裸体啪啪无遮挡网站| 日本wwww免费看| 人妻人人澡人人爽人人| 亚洲国产精品国产精品| 看十八女毛片水多多多| 亚洲男人天堂网一区| 精品国产乱码久久久久久小说| 国产精品av久久久久免费| 成人毛片a级毛片在线播放| av免费在线看不卡| 日日摸夜夜添夜夜爱| 国产精品99久久99久久久不卡 | 国产无遮挡羞羞视频在线观看| 精品人妻在线不人妻| 精品国产露脸久久av麻豆| 亚洲内射少妇av| 有码 亚洲区| 免费日韩欧美在线观看| 亚洲欧美色中文字幕在线| 日韩 亚洲 欧美在线| 成人二区视频| 日韩电影二区| 99国产精品免费福利视频| 亚洲一区二区三区欧美精品| 自拍欧美九色日韩亚洲蝌蚪91| 久久国产亚洲av麻豆专区| 国产成人欧美| 亚洲欧美成人精品一区二区| 汤姆久久久久久久影院中文字幕| 久久久久人妻精品一区果冻| 在线观看美女被高潮喷水网站| 久久鲁丝午夜福利片| 亚洲成色77777| 亚洲第一区二区三区不卡| 亚洲精品久久久久久婷婷小说| av网站在线播放免费| 王馨瑶露胸无遮挡在线观看| 国产乱来视频区| 黄色 视频免费看| a级片在线免费高清观看视频| 在线天堂最新版资源| 欧美日韩精品成人综合77777| √禁漫天堂资源中文www| 久久鲁丝午夜福利片| 91午夜精品亚洲一区二区三区| 午夜福利一区二区在线看| 国产成人精品在线电影| 久久亚洲国产成人精品v| 久久国产精品大桥未久av| 美女脱内裤让男人舔精品视频| 日本-黄色视频高清免费观看| 成人国产av品久久久| 亚洲精品国产av成人精品| 免费看av在线观看网站| 国产成人一区二区在线| 大香蕉久久成人网| 免费久久久久久久精品成人欧美视频| 一区二区三区乱码不卡18| 啦啦啦啦在线视频资源| 亚洲成av片中文字幕在线观看 | 好男人视频免费观看在线| 亚洲国产精品国产精品| 午夜福利在线观看免费完整高清在| av一本久久久久| 少妇 在线观看| 麻豆精品久久久久久蜜桃| 亚洲精品一二三| 免费播放大片免费观看视频在线观看| 一级毛片电影观看| 国产精品久久久久久精品电影小说| 国产亚洲精品第一综合不卡| 亚洲第一区二区三区不卡| 亚洲国产欧美在线一区| 久久国内精品自在自线图片| 亚洲欧美色中文字幕在线| 男女免费视频国产| 啦啦啦在线观看免费高清www| 曰老女人黄片| 欧美97在线视频| 交换朋友夫妻互换小说| 精品一区在线观看国产| 最近的中文字幕免费完整| 宅男免费午夜| 国产精品国产三级专区第一集| 国产一区二区 视频在线| 超碰97精品在线观看| 精品少妇黑人巨大在线播放| 最黄视频免费看| 丝袜美足系列| 久久人人爽人人片av| av网站在线播放免费| 久久精品久久精品一区二区三区| 999精品在线视频| 人人妻人人爽人人添夜夜欢视频| 亚洲精品自拍成人| 国产精品欧美亚洲77777| 黄片播放在线免费| 欧美另类一区| 综合色丁香网| 久久久久久久国产电影| 国产探花极品一区二区| av又黄又爽大尺度在线免费看| 久久精品夜色国产| 1024香蕉在线观看| 91国产中文字幕| 看免费av毛片| 伊人久久国产一区二区| 中文天堂在线官网| 久久ye,这里只有精品| 韩国高清视频一区二区三区| 国产探花极品一区二区| 久久这里只有精品19| 一本久久精品| 美女午夜性视频免费| 一级,二级,三级黄色视频| 天堂8中文在线网| 亚洲图色成人| 最近中文字幕2019免费版| av又黄又爽大尺度在线免费看| 九色亚洲精品在线播放| 中文字幕人妻丝袜一区二区 | 亚洲美女黄色视频免费看| 午夜福利视频精品| 欧美精品高潮呻吟av久久| 日韩av在线免费看完整版不卡| 午夜免费鲁丝| 亚洲精品国产av蜜桃| 免费观看av网站的网址| 激情五月婷婷亚洲| 欧美国产精品va在线观看不卡| 日日摸夜夜添夜夜爱| 色婷婷久久久亚洲欧美| 亚洲欧美中文字幕日韩二区| 精品卡一卡二卡四卡免费| 一级爰片在线观看| 亚洲精品久久久久久婷婷小说| 9191精品国产免费久久| 一区二区三区激情视频| 国产xxxxx性猛交| 1024视频免费在线观看| 久久97久久精品| 国产亚洲av片在线观看秒播厂| 天堂中文最新版在线下载| 啦啦啦在线观看免费高清www| 亚洲三区欧美一区| 久久精品国产亚洲av涩爱| 久久精品久久久久久噜噜老黄| 高清欧美精品videossex| 80岁老熟妇乱子伦牲交| 哪个播放器可以免费观看大片| 丝袜美足系列| 新久久久久国产一级毛片| 母亲3免费完整高清在线观看 | av不卡在线播放| 少妇被粗大的猛进出69影院| 日本av免费视频播放| 综合色丁香网| 精品人妻一区二区三区麻豆| 久久精品国产自在天天线| 韩国高清视频一区二区三区| 久久久亚洲精品成人影院| 咕卡用的链子| 老司机影院毛片| 免费观看性生交大片5| 欧美变态另类bdsm刘玥| 国产亚洲最大av| 国产日韩欧美在线精品| 国产精品亚洲av一区麻豆 | 最近中文字幕2019免费版| 国产成人免费无遮挡视频| 十八禁网站网址无遮挡| 免费观看性生交大片5| 深夜精品福利| 国产精品女同一区二区软件| 国产精品二区激情视频| 久久综合国产亚洲精品| 尾随美女入室| 人人妻人人添人人爽欧美一区卜| 国产一区二区三区综合在线观看| 国产精品女同一区二区软件| 亚洲欧美成人精品一区二区| 亚洲精品国产一区二区精华液| 中文字幕制服av| 叶爱在线成人免费视频播放| 久久久精品国产亚洲av高清涩受| 男人爽女人下面视频在线观看| 亚洲视频免费观看视频| 国产 一区精品| 美国免费a级毛片| 久久久久久久亚洲中文字幕| 成人黄色视频免费在线看| a级毛片黄视频| 成人免费观看视频高清| 久久精品国产自在天天线| 中文字幕精品免费在线观看视频| 日韩在线高清观看一区二区三区| 亚洲综合色惰| 黄网站色视频无遮挡免费观看| 最近中文字幕2019免费版| www.熟女人妻精品国产| 久久久久久久大尺度免费视频| 亚洲精品aⅴ在线观看| 午夜免费鲁丝| 男人添女人高潮全过程视频| 国产国语露脸激情在线看| 国产精品熟女久久久久浪| www.av在线官网国产| 欧美中文综合在线视频| 999精品在线视频| 午夜福利网站1000一区二区三区| 欧美日韩视频高清一区二区三区二| 亚洲第一av免费看| 观看av在线不卡| 狂野欧美激情性bbbbbb| 日韩人妻精品一区2区三区| 国产精品久久久久久精品电影小说| 国产成人精品无人区| 成年人午夜在线观看视频| 纵有疾风起免费观看全集完整版| 亚洲国产最新在线播放| 熟女av电影| av又黄又爽大尺度在线免费看| 一本久久精品| 欧美黄色片欧美黄色片| 免费播放大片免费观看视频在线观看| 九色亚洲精品在线播放| 精品酒店卫生间| www.熟女人妻精品国产| 女人高潮潮喷娇喘18禁视频| 国产黄色免费在线视频| 91精品国产国语对白视频| 80岁老熟妇乱子伦牲交| 色婷婷av一区二区三区视频| 亚洲精品国产av成人精品| 91精品国产国语对白视频| 精品人妻一区二区三区麻豆| 免费观看a级毛片全部| 国产黄色视频一区二区在线观看| 亚洲av电影在线进入| 国产视频首页在线观看| 男人添女人高潮全过程视频| 一区二区av电影网| 亚洲五月色婷婷综合| 欧美激情极品国产一区二区三区| 自拍欧美九色日韩亚洲蝌蚪91| 亚洲国产成人一精品久久久| 这个男人来自地球电影免费观看 | 多毛熟女@视频| 伊人久久大香线蕉亚洲五| 美女大奶头黄色视频| 好男人视频免费观看在线| 欧美+日韩+精品| 亚洲国产欧美在线一区| 日韩制服丝袜自拍偷拍| 制服诱惑二区| 九色亚洲精品在线播放| 免费观看在线日韩| 中文字幕av电影在线播放| 国产成人午夜福利电影在线观看| 日韩大片免费观看网站| 狠狠精品人妻久久久久久综合| 国产精品国产三级专区第一集| 亚洲av免费高清在线观看| 五月开心婷婷网| 两个人看的免费小视频| 男女无遮挡免费网站观看| 亚洲av.av天堂| 久久久久久久国产电影| 极品人妻少妇av视频| 亚洲国产毛片av蜜桃av| 国产男女内射视频| 少妇被粗大的猛进出69影院| 久久99热这里只频精品6学生| 久久精品人人爽人人爽视色| 99久国产av精品国产电影| 久久久久久久久久久久大奶| 成人二区视频| 色婷婷av一区二区三区视频| 久久精品熟女亚洲av麻豆精品| 一区在线观看完整版| 丝袜喷水一区| 一级毛片电影观看| 亚洲国产日韩一区二区| 丰满少妇做爰视频| 午夜福利在线观看免费完整高清在| 国产片特级美女逼逼视频| 亚洲精品日韩在线中文字幕| 亚洲国产成人一精品久久久| 一本色道久久久久久精品综合| 日本欧美视频一区| www.精华液| 伦精品一区二区三区| 美女福利国产在线| 高清黄色对白视频在线免费看| 一级黄片播放器| 久久精品亚洲av国产电影网| 老熟女久久久| 午夜久久久在线观看| 18+在线观看网站| 欧美日韩视频高清一区二区三区二| 高清视频免费观看一区二区| videossex国产| 国产成人精品无人区| 人妻系列 视频| 国产精品无大码| 精品国产超薄肉色丝袜足j| 久久免费观看电影| 日本欧美国产在线视频| 日本免费在线观看一区| 日本爱情动作片www.在线观看| 亚洲精品久久成人aⅴ小说| 亚洲精品乱久久久久久| 丝瓜视频免费看黄片| 中文字幕人妻熟女乱码| 国产成人欧美| 91国产中文字幕| 免费人妻精品一区二区三区视频| a 毛片基地| 欧美xxⅹ黑人| 又黄又粗又硬又大视频| 日本免费在线观看一区| 国产在视频线精品| 国产av精品麻豆| www.熟女人妻精品国产| 国产又色又爽无遮挡免| 欧美另类一区| 日韩一区二区视频免费看| 亚洲精品国产一区二区精华液| 国产xxxxx性猛交| 欧美日韩亚洲国产一区二区在线观看 | 少妇 在线观看| 久久99一区二区三区| 免费在线观看视频国产中文字幕亚洲 | 最近中文字幕高清免费大全6| 亚洲少妇的诱惑av| 日韩三级伦理在线观看| 美女中出高潮动态图| 免费观看a级毛片全部| 9热在线视频观看99| 亚洲av欧美aⅴ国产| 亚洲五月色婷婷综合| 一级片免费观看大全| 免费黄色在线免费观看| 91国产中文字幕| 三上悠亚av全集在线观看| 成人黄色视频免费在线看| 亚洲国产成人一精品久久久| 欧美人与性动交α欧美精品济南到 | 国产精品久久久久久精品电影小说| 国产精品 国内视频| 免费日韩欧美在线观看| 亚洲av国产av综合av卡| 999精品在线视频| 亚洲美女视频黄频| 午夜福利视频在线观看免费| 国产麻豆69| 韩国精品一区二区三区| 69精品国产乱码久久久| 精品国产超薄肉色丝袜足j| 人成视频在线观看免费观看| 美女国产高潮福利片在线看| 久久免费观看电影| 久久人人爽人人片av| 欧美亚洲 丝袜 人妻 在线| 侵犯人妻中文字幕一二三四区| 美女大奶头黄色视频| 97精品久久久久久久久久精品| 大话2 男鬼变身卡| 婷婷色综合www| av.在线天堂| 在线 av 中文字幕| 色网站视频免费| 亚洲欧美清纯卡通| 免费观看av网站的网址| 五月天丁香电影| 纵有疾风起免费观看全集完整版| 欧美精品亚洲一区二区| 男女下面插进去视频免费观看| 九色亚洲精品在线播放| 亚洲精品自拍成人| 一区二区三区激情视频| 国产精品一国产av| 999精品在线视频| 久久精品久久久久久噜噜老黄| 一区二区三区激情视频| 哪个播放器可以免费观看大片| 国产爽快片一区二区三区| 一级毛片 在线播放| 亚洲三级黄色毛片| 国产人伦9x9x在线观看 | 黄色毛片三级朝国网站| 日本免费在线观看一区| 亚洲精品第二区| 69精品国产乱码久久久| 久久久国产欧美日韩av| 欧美日韩亚洲国产一区二区在线观看 | 日韩,欧美,国产一区二区三区| 熟女少妇亚洲综合色aaa.| 亚洲国产毛片av蜜桃av| 高清av免费在线| 国产又色又爽无遮挡免| 我的亚洲天堂| 岛国毛片在线播放| 人妻人人澡人人爽人人| 高清黄色对白视频在线免费看| 少妇 在线观看| 午夜av观看不卡| 国产成人精品无人区| www.熟女人妻精品国产| 国产精品二区激情视频| 久久韩国三级中文字幕| 日本免费在线观看一区| 黄色视频在线播放观看不卡| 亚洲精品日韩在线中文字幕| 香蕉精品网在线| 久久久久久伊人网av| 亚洲伊人色综图| 亚洲内射少妇av| 人妻一区二区av| 久久青草综合色| 人体艺术视频欧美日本| www日本在线高清视频| 国产成人精品久久二区二区91 | 欧美另类一区| 伦精品一区二区三区| 午夜福利视频精品| 永久网站在线| 九色亚洲精品在线播放| 如日韩欧美国产精品一区二区三区| 久久久久久人妻| 视频区图区小说| 久久久国产欧美日韩av| 国产精品 欧美亚洲| 尾随美女入室| 精品少妇内射三级| 在线看a的网站| 一区二区三区激情视频| 成人国产麻豆网| 日本欧美视频一区| 精品第一国产精品| 亚洲人成77777在线视频| 亚洲欧美清纯卡通| 亚洲av中文av极速乱| 韩国高清视频一区二区三区| 国产极品粉嫩免费观看在线| 国产日韩欧美在线精品| 久久久久人妻精品一区果冻| 熟女av电影| 精品国产国语对白av| 母亲3免费完整高清在线观看 | 国产一区二区三区综合在线观看| 久久精品国产综合久久久| 精品国产乱码久久久久久男人| 国产黄色视频一区二区在线观看| 欧美精品一区二区免费开放| 老熟女久久久| 免费久久久久久久精品成人欧美视频|